Morgan Stanley’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.5K | Sell |
2,536
-109
| -4% | -$3.68K | ﹤0.01% | 6187 |
|
|
2025
Q1 | $84.1K | Buy |
2,645
+44
| +2% | +$1.4K | ﹤0.01% | 6092 |
|
|
2024
Q4 | $101K | Sell |
2,601
-235
| -8% | -$9.13K | ﹤0.01% | 6055 |
|
|
2024
Q3 | $128K | Sell |
2,836
-464
| -14% | -$20.9K | ﹤0.01% | 5903 |
|
|
2024
Q2 | $138K | Sell |
3,300
-92
| -3% | -$3.84K | ﹤0.01% | 5841 |
|
|
2024
Q1 | $154K | Sell |
3,392
-2,890
| -46% | -$132K | ﹤0.01% | 5819 |
|
|
2023
Q4 | $290K | Buy |
6,282
+3,141
| +100% | +$145K | ﹤0.01% | 5804 |
|
|
2023
Q3 | $128K | Sell |
3,141
-75
| -2% | -$3.05K | ﹤0.01% | 5768 |
|
|
2023
Q2 | $156K | Sell |
3,216
-237
| -7% | -$11.5K | ﹤0.01% | 5750 |
|
|
2023
Q1 | $170K | Buy |
3,453
+2,493
| +260% | +$123K | ﹤0.01% | 5783 |
|
|
2022
Q4 | $48.6K | Sell |
960
-1,947
| -67% | -$98.5K | ﹤0.01% | 6303 |
|
|
2022
Q3 | $146K | Buy |
2,907
+45
| +2% | +$2.26K | ﹤0.01% | 5890 |
|
|
2022
Q2 | $140K | Hold |
2,862
| – | – | ﹤0.01% | 6090 |
|
|
2022
Q1 | $172K | Sell |
2,862
-81
| -3% | -$4.87K | ﹤0.01% | 6001 |
|
|
2021
Q4 | $234K | Sell |
2,943
-110
| -4% | -$8.75K | ﹤0.01% | 5983 |
|
|
2021
Q3 | $271K | Buy |
3,053
+81
| +3% | +$7.19K | ﹤0.01% | 5837 |
|
|
2021
Q2 | $296K | Sell |
2,972
-194
| -6% | -$19.3K | ﹤0.01% | 5818 |
|
|
2021
Q1 | $284K | Buy |
3,166
+2,160
| +215% | +$194K | ﹤0.01% | 5461 |
|
|
2020
Q4 | $95K | Buy |
1,006
+925
| +1,142% | +$87.4K | ﹤0.01% | 5931 |
|
|
2020
Q3 | $6K | Buy |
+81
| New | +$6K | ﹤0.01% | 6408 |
|